'Next Ozempic' aims to deliver 30% weight loss with fewer side effects

Sep 08, 2025, 11:00 AM

AI Token: NONE (NONE)

'Next Ozempic' aims to deliver 30% weight loss with fewer side effects

Price

—

Market Cap

—

Volume (24h)

—

Liquidity

—

Scientists have created a pre-clinical weight loss drug combining GLP-1, GIP, glucagon and peptide YY hormones to match bariatric surgery effectiveness.

Read original source →

'Next Ozempic' aims to deliver 30% weight loss with fewer side effects — Forever